Structure |
Chemical Name |
CAS |
MF |
|
Macitentan Hydroxy amine Impurity |
2211059-05-9 |
C12H12BrN3O2 |
|
1,3-diethyl-1,3-dimethylurea |
31468-19-6 |
C7H16N2O |
|
7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, ethyl ester |
7029-96-1 |
C11H14N4O4 |
|
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide |
|
|
|
Rifampin Impurity 6 |
|
|
|
Cefuroxime Dioxide Impurity(Cefuroxime Sulfoxide) |
|
|
|
Ampicillin Impurity F(USP) |
|
|
|
Miconazole Impurity G(EP) |
1370335-40-2 |
C18H14Cl4N2O |
|
2-chloro-1-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
|
2-(5H-chromeno[2,3-b]pyridin-7-yl)acrylic acid |
52549-22-1 |
C15H11NO3 |
|
1-(6-chloro-5-fluoropyrimidin-4-yl)ethanol |
1289559-76-7 |
C6H6ClFN2O |
|
Fluoxetine Impurity 29,methyl({3-phenyl-3-[2-(trifluoromethyl)phenoxy]propyl})amine |
56161-71-8 |
C17H18F3NO |
|
(Z)-4-chloro-6-(3-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-yl)but-3-en-2-yl)-5-fluoropyrimidine |
|
|
|
Ceftriaxone sodium impurity 09 |
|
|
|
Cefradine Impurity 8 |
30959-67-2 |
C16H19N3O4S |
|
Biotin Impurity |
171232-73-8 |
C19H18N2O2S |
|
PANTOPRAZOLE N-OXIDE |
953787-60-5 |
C16H15F2N3O5S |
|
N-(3-GUANIDINO-4-METHYLPHENYL)-4-(METHYLPIPERAZINE-1-YL-METHYL)BENZAMIDE |
581076-65-5 |
C21H28N6O |
|
Tirofiban-d9 Hydrochloride |
1331911-68-2 |
C22H37ClN2O5S |
|
Ibuprofen Alcohol |
36039-36-8 |
C13H20O |
|
1,1-BIS-(4-ISOBUTYLPHENYL)ETHANE |
102120-87-6 |
C22H30 |
|
Sugammadex sodium Impurity 52 |
|
|
|
Sugammadex sodium Impurity 43 |
|
|
|
Sugammadex sodium Impurity 39 |
|
|
|
Cefazolin Impurity EP-J |
|
|
|
Cabozantinib impurity 41 |
|
|
|
Cabozantinib impurity 67 |
|
|
|
Dapoxetine impurity 50 |
|
|
|
Doxofylline Impurity 18 |
|
|
|
Dapoxetine impurity 63 |
|
|
|
Dapoxetine impurity 57 |
|
|
|
Bosutinib Impurity 2 (N-Desmethyl Bosutinib) |
380843-81-2 |
C25H27Cl2N5O3 |
|
4-PYRIDINECARBOXIMIDIC ACID, HYDRAZIDE |
89830-71-7 |
C6H8N4 |
|
2-PENTANOYLBENZOIC ACID |
550-37-8 |
C12H14O3 |
|
Chloromethyl ethyl carbonate |
35179-98-7 |
C4H7ClO3 |
|
Bimatoprost Impurity 10 |
|
|
|
Carbetocin S-Oxide II |
|
|
|
Empagliflozin Impurity 82 |
2452301-16-3 |
C17H16ClIO2 |
|
Empagliflozin Impurity 88 |
|
|
|
Tofacitinib Impurity K |
2328165-36-0 |
C16H21N5O3 |
|
Olopatadine Impurity 13 |
55453-90-2 |
C18H16O4 |
|
4-((2-amino-2-oxoethyl)amino)butanoic acid |
1096803-44-9 |
C6H12N2O3 |
|
Lenvatinib impurity LFZZ-17 |
|
C11H9NO4 |
|
Ornidazole Impurity 25 |
|
|
|
Pitavastatin Impurity 72 |
|
|
|
Febuxostat Impurity 109 |
|
|
|
Brivaracetam Impurity 37 |
|
|
|
Ticagrelor Impurity 133 |
|
|
|
4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide |
1187188-59-5 |
C14H12BNO4 |
|
2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]- |
219915-41-0 |
C10H10O3 |
|
L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]- |
61475-35-2 |
C5H9NO5S |
|
Phenol, 2-(2-phenyldiazenyl)- |
2362-57-4 |
C12H10N2O |
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo- |
2410658-30-7 |
C15H14FNO5 |
|
Hexanoic acid, 3-(hydroxymethyl)- |
81381-87-5 |
C7H14O3 |
|
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
936226-36-7 |
C30H36N6O10S2 |
|
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)- |
946525-39-9 |
C22H27ClO6 |
|
Topiroxostat Impurity 42 |
|
|
|
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
|
Regorafenib Impurity MHY |
|
|
|
Lumateperone Impurity 6 |
313368-82-0 |
C23H26FN3O |
|
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid) |
|
|
|
4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1307315-04-3 |
C16H13BrF3N5O |
|
Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- |
2247538-61-8 |
C23H30FN3O2 |
|
Vonoprazan Impurity B-3 |
|
|
|
3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-51-2 |
C16H19N7O3S |
|
Budesonide Impurity 26 |
|
|
|
Peramivir Impurity 48 |
|
|
|
Tolvaptan dehydroxylated impurity |
|
|
|
3-Quinolinemethanol, 2-cyclopropyl-4-phenyl- |
2153433-73-7 |
C19H17NO |
|
Piperacillin ImpurityABCDEFGHI |
|
|
|
5,6-DIMETHOXY-2-PYRIDIN-4-YLMETHYL-INDAN-1-ONE |
4803-57-0 |
C17H17NO3 |
|
3-(Dimethylamino)-1-(2-thienyl)-1-propanol |
13636-02-7 |
C9H15NOS |
|
Benzamide, 2,5-dichloro-N-(3-methylbutyl)- |
349086-08-4 |
C12H15Cl2NO |
|
BECLOTIAMINE |
13471-78-8 |
C12H16Cl2N4S |
|
methyl 5-sulpho-o-anisate |
94134-07-3 |
C9H10O6S |
|
2,4-Dioxo-3-azaspiro[5.5]undecan-1,5-dicarbonitril |
4355-15-1 |
C12H13N3O2 |
|
INDEX NAME NOT YET ASSIGNED |
2412953-11-6 |
C72H112O49S8 |
|
Sulfamide, N-[5-phenyl-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N'-propyl- |
2300968-85-6 |
C19H22N6O4S |
|
Acetamide, 2-chloro-N-(2-chloroacetyl)-N-(2,6-dimethylphenyl)- |
112843-97-7 |
C12H13Cl2NO2 |
|
1-[2-Cyan-1-(cyanimino)ethyl]piperidin |
56488-00-7 |
C9H12N4 |
|
Oseltamivir Impurity 99 |
|
|
|
Oseltamivir Impurity 92 |
|
|
|
Oseltamivir Impurity 76 |
|
|
|
Regorafenib Impurity ABCDEFGHJKL |
|
|
|
(S)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)-1-iminohexahydro pyrrolo[1,2-a]pyrazin-4(1H)-one hydrochloride |
|
|
|
Benzonitrile, 4-[2-[(1R,2S)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-, rel- |
1797905-83-9 |
C22H17F2N5OS |
|
3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2S,3S,4R,5S)- |
1550201-56-3 |
C8H17NO5 |
|
1-(2,4-difluoro-6-hydroxyphenyl)prop-2-en-1-one |
|
|
|
1-(4-Fluorphenyl)-1,3-dihydro-1-[3-(methylamino)propyl]isobenzofuran-5-carbonitril |
62498-67-3 |
C19H19FN2O |
|
17-α,21-Dihydroxy-16-α-methylpregna-1,4,9(11)-trien-3,20-dion-21-acetat |
10106-41-9 |
C24H30O5 |
|
2-chloro-N-(2,4-dimethylphenyl)acetamide |
39106-10-0 |
C10H12ClNO |
|
Natrium-[2S-(2α,5α,6β)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat |
73335-78-1 |
C8H9BrNNaO3S |
|
2-Amino-1-(3,4-dihydroxyphenyl)ethan-1-on |
499-61-6 |
C8H9NO3 |
|
Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester |
2267259-70-9 |
C17H17NO10S2 |
|
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-2-methyl-7-oxo-, (S)- (9CI) |
129798-65-8 |
C13H9F2NO4 |
|
Sitagliptin EP Impurity 1 |
|
|
|
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αS,3aR,4R,6R,7aS)-, 2,2,2-trifluoroacetate (1:1) |
2363753-29-9 |
C17H29BF3NO4 |
|
Beprostatin impurity 3 |
|
|
|
endo-(±)-8-Aza-8-isopropylbicyclo[3.2.1]oct-3-yl-(hydroxymethyl)phenylacetat |
22235-81-0 |
C19H27NO3 |
|
8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)- |
1654737-35-5 |
C29H44N12O10 |